Plus Therapeutics Inc (PSTV): Next-Year EPS Estimate 38.89%
As of 2026-06-04, Plus Therapeutics Inc (PSTV) has a next-year EPS growth estimate of 38.89%.
On 2026-05-19, analyst consensus for PSTV's next-year EPS growth shifted from 38.92% to 38.89% — a negative change of 0.03 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 46.62%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 38.89%
- EPS growth this year
- 46.62%
- EPS next quarter (est)
- -$0.90
- Last price
- $5.74
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 38.89% | 46.62% | -$0.90 | $5.74 |
| 2026-06-03 | 38.89% | 46.62% | -$0.90 | $5.42 |
| 2026-06-02 | 38.89% | 46.62% | -$0.90 | $5.47 |
| 2026-06-01 | 38.89% | 46.62% | -$0.90 | $5.70 |
| 2026-05-31 | 38.89% | 46.62% | -$0.90 | $5.82 |
| 2026-05-28 | 38.89% | 46.62% | -$0.90 | $6.43 |
| 2026-05-27 | 38.89% | 46.62% | -$0.90 | $6.64 |
| 2026-05-26 | 38.89% | 46.62% | -$0.90 | $6.60 |
| 2026-05-25 | 38.89% | 46.62% | -$0.90 | $6.59 |
| 2026-05-24 | 38.89% | 46.62% | -$0.90 | $6.59 |
| 2026-05-21 | 38.89% | 46.62% | -$0.81 | $6.89 |
| 2026-05-20 | 38.89% | 46.62% | -$0.81 | $6.43 |
| 2026-05-19 | 38.89% | 46.62% | -$0.81 | $5.83 |
| 2026-05-18 | 38.92% | 46.93% | -$0.80 | $5.84 |
| 2026-05-17 | 38.92% | 46.93% | -$0.80 | $5.25 |
| 2026-05-14 | 38.92% | 46.93% | -$0.85 | $5.76 |
| 2026-05-13 | 38.92% | 46.93% | -$0.85 | $5.80 |
| 2026-05-12 | 38.92% | 46.93% | -$0.85 | $5.85 |
| 2026-05-11 | 38.92% | 46.93% | -$0.85 | $6.04 |
| 2026-05-10 | 38.92% | 46.93% | -$0.85 | $6.12 |
| 2026-05-07 | 38.31% | 47.34% | -$0.85 | $5.95 |
| 2026-05-06 | 38.31% | 47.34% | -$0.85 | $6.00 |
| 2026-05-05 | 38.31% | 47.34% | -$0.85 | $6.22 |
| 2026-05-04 | 38.31% | 47.34% | -$0.85 | $6.30 |
| 2026-05-03 | 38.31% | 47.34% | -$0.85 | $6.09 |
| 2026-04-30 | 38.31% | 47.34% | -$0.85 | $6.14 |
| 2026-04-29 | 38.31% | 47.34% | -$0.85 | $5.60 |
| 2026-04-28 | 38.22% | 52.36% | -$0.85 | $5.95 |
| 2026-04-27 | 38.22% | 52.36% | -$0.85 | $5.99 |
| 2026-04-26 | 38.22% | 52.36% | -$0.85 | $6.60 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Plus Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Plus Therapeutics Inc (PSTV) has a next-year EPS growth estimate of 38.89%, based on analyst consensus.
When was the latest EPS estimate revision for PSTV?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 38.92% to 38.89%.
What sector and industry does Plus Therapeutics Inc belong to?▾
Plus Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PSTV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Plus Therapeutics Inc (PSTV) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports